| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |